Trial failure forces Xenova cutbacks
October 28, 2003Research and Development
Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about …
Six-month delay could be fatal for GP contract
October 28, 2003The crisis surrounding the proposed new GP contract has deepened after doctors refused to be "stampeded" into accepting a new …
Hassan hits the ground running on Schering-Plough re-organisation
October 28, 2003Sales and Marketing
Fred Hassan has announced a major re-organisation of Schering-Plough's pharmaceutical operations just 17 days after taking on the job of …
UK’s pharmaceutical profit control scheme to be reviewed
October 28, 2003Sales and Marketing
The agreement between the UK government and the pharmaceutical industry which controls company profits is to be reviewed.Introduced in 1999, …
Roche launches first proactive patient helpline
October 28, 2003Medical Communications, Sales and Marketing
Roche and health call-centre specialists International SOS have launched the UK's first ever helpline to proactively support patients to keep …
Private sector invited to run NHS surgery centres
October 28, 2003Private sector companies have been invited to run the latest wave of new diagnostic treatment centres (DTC) to help cut …
European HRT safety probe launched
October 28, 2003Sales and Marketing
The European Union medicines regulator is to investigate the safety of hormone replacement therapy products following a new study was …
UK research centre falls victim to Pfizer merger
October 28, 2003Research and Development
A leading UK drug discovery centre is one of a number of global sites to close following Pfizer's recently completed …
Roche’s targeted cancer drug fails
October 28, 2003Research and Development
A new type of cancer drug developed by Roche, Genentech and OSI Pharmaceuticals has failed to prove its efficacy in …
Rebels fail to halt foundation trust plans
October 28, 2003The Government has won a crucial House of Commons vote in favour of its plans to allow top-performing hospitals to …
New data boosts AstraZeneca’s Atacand
October 28, 2003Research and Development, Sales and Marketing
New trial data on AstraZeneca's blood pressure treatment Atacand could give the drug a lead over rivals in the same …
Latest content
FibroFind appoints Lee Borthwick as CEO
